54-BICR350 - mirtazapine-n-oxide | 155172-12-6
Sorry, no product with reference 54-BICR350 been found, but please check out the following similar products:
Mirtazapine EP Impurity A (Mirtazapine N-Oxide) (Mixture of Diastereomers)
CAS:Formula:C17H19N3OColor and Shape:White To Off-White SolidMolecular weight:281.36Mirtazapine N-oxide
CAS:Mirtazapine N-oxide, a mirtazapine metabolite, is produced by CYP1A2 and CYP3A4 in human liver.Formula:C17H19N3OColor and Shape:SolidMolecular weight:281.359Mirtazapine N-oxide
CAS:<p>Mirtazapine N-oxide is an antidepressant agent that is metabolized to mirtazapine. Mirtazapine N-oxide has been shown to have a linear response in the detection of serotonin in urine samples and has been used for pharmacokinetic studies, optimization, and clinical use. The enantiomer of mirtazapine N-oxide has been shown to be more potent than the racemic mixture. The drug is excreted unchanged into the urine with a half-life of 2 hours. Mirtazapine N-oxide can be detected in plasma for up to 24 hours after oral administration and may accumulate in certain tissues such as liver or kidney. This drug has also been shown to cause death in mice at very high doses.</p>Formula:C17H19N3OPurity:Min. 95%Molecular weight:281.35 g/mol(14bRS)-2-Methyl-1,2,3,4,10-14b-hexahydropyrazino[2,1-a]pyrido[2,3-c][2]benzazepine 2-Oxide
CAS:Controlled ProductFormula:C17H19N3OColor and Shape:NeatMolecular weight:281.35Mirtazapine N-Oxide (1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]benzazepine 2-oxide)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C17H19N3OColor and Shape:White PowderMolecular weight:281.15281









